- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
B2M Antibody (C-term Y86) Blocking PeptideSynthetic peptide
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| BP2771d | 0.1 mg 400 ul | In Stock | $ 45.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
B2M Antibody (C-term Y86) Blocking Peptide - Product info | |
| Primary Accession | P61769 |
| Clone Names | 80808004 |
| Calculated MW | 13715 Da |
B2M Antibody (C-term Y86) Blocking Peptide - Additional info | |
| Gene ID 567 | |
| Target/Specificity The synthetic peptide sequence used to generate the antibody AP2771d was selected from the C-term region of human B2M. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. | |
| Format Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. | |
| Precautions This product is for research use only. Not for use in diagnostic or therapeutic procedures. | |
B2M Antibody (C-term Y86) Blocking Peptide - Protein Information | |
| Name B2M | |
| Function Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system | |
| Cellular Location Secreted. Note=Detected in serum and urine. | |
B2M Antibody (C-term Y86) Blocking Peptide - Related products
AP2771a: B2M Antibody (N-term)
AP2771b: B2M Antibody (C-term)
AP2771d: B2M Antibody (C-term Y86)
BP2771a: B2M Antibody (N-term) Blocking Peptide
BP2771b: B2M Antibody (C-term) Blocking Peptide
BP2771d: B2M Antibody (C-term Y86) Blocking Peptide
B2M Antibody (C-term Y86) Blocking Peptide - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Beta-2-microglobulin is a serum protein found in association with the major histocompatibility complex (MHC) class I heavy chain on the surface of nearly all nucleated cells.
REFERENCES
Sakata,M., J. Mol. Biol. 382 (5), 1242-1255 (2008)Huang,W.C., Clin. Cancer Res. 14 (17), 5341-5347 (2008)Gattoni-Celli,S., Cancer Res. 52 (5), 1201-1204 (1992)
